A UK study (6) found meningiomas more common in GH-treated, brain-irradiated cancer patients than in matched, brain-irradiated cancer controls, but based on small numbers, and a later analysis from the US cohort did not find raised meningioma risk (7). Here, GH1 is linked to meningioma.